The integration of the Sanofi-Aventis manufacturing site in Madrid within Famar network is now official. As of July 1st the two parties came to a written agreement finalizing the framework and the principles of the collaboration. The site, which produces both solid and sterile forms and supplies more than 50 markets, will serve as an additional platform for developing Famar’s service offering.
Famar will continue to supply Sanofi-Aventis with certain products from the site on the basis of a strong and sustainable supply agreement. In addition, as part of this project, Famar has launched a significant investment plan to expand the plant’s sterile capacities and offering. The plan involves the creation of a new 1000m2 sterile core with two compounding rooms, linked to three filling and packaging lines.
The new are will be focused on sterile ophthalmic and nasal spray products with an annual capacity ranging between 30 and 35 mio consumer units. The area will be operational at the end of Q4 2011.